BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25755323)

  • 1. ABCB4 Disease Presenting with Cirrhosis and Copper Overload-Potential Confusion with Wilson Disease.
    Shneider BL
    J Clin Exp Hepatol; 2011 Sep; 1(2):115-7. PubMed ID: 25755323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report.
    Qiao F; Ren F; Lu W; Yang H; Mo G; Wang S; Liu L; Xu X
    BMC Med Genomics; 2023 Jul; 16(1):171. PubMed ID: 37488596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCB4 Mutations in Adults Cause a Spectrum Cholestatic Disorder Histologically Distinct from Other Biliary Disease.
    Sinha A; Bhuva M; Grant C; Gimson AE; Thompson E; Duckworth A; Davies SE; Aithal G; Griffiths WJ
    Dig Dis Sci; 2022 Dec; 67(12):5551-5561. PubMed ID: 35288833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCB4 disease: Many faces of one gene deficiency.
    Sticova E; Jirsa M
    Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
    Stättermayer AF; Halilbasic E; Wrba F; Ferenci P; Trauner M
    J Hepatol; 2020 Sep; 73(3):651-663. PubMed ID: 32376413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese children with chronic intrahepatic cholestasis and high γ-glutamyl transpeptidase: clinical features and association with ABCB4 mutations.
    Fang LJ; Wang XH; Knisely AS; Yu H; Lu Y; Liu LY; Wang JS
    J Pediatr Gastroenterol Nutr; 2012 Aug; 55(2):150-6. PubMed ID: 22343912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults.
    Gotthardt D; Runz H; Keitel V; Fischer C; Flechtenmacher C; Wirtenberger M; Weiss KH; Imparato S; Braun A; Hemminki K; Stremmel W; Rüschendorf F; Stiehl A; Kubitz R; Burwinkel B; Schirmacher P; Knisely AS; Zschocke J; Sauer P
    Hepatology; 2008 Oct; 48(4):1157-66. PubMed ID: 18781607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed.
    Avena A; Puggelli S; Morris M; Cerny A; Andrade AR; Pareti E; Bihl F; Cassatella D; Moix I; Merlo E; Rougemont AL; Majno-Hurst P; Vergani D; Mieli-Vergani G; Terziroli Beretta-Piccoli B
    Dig Liver Dis; 2021 Mar; 53(3):329-344. PubMed ID: 33390354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCB4 disease mimicking morbus Wilson: A potential diagnostic pitfall.
    Sticova E; Neroldova M; Kotalova R; Subhanova I; Jirsa M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):121-125. PubMed ID: 31728073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous mutations of ATP8B1, ABCB11 and ABCB4 cause mild forms of Progressive Familial Intrahepatic Cholestasis in a pediatric cohort.
    Mínguez Rodríguez B; Molera Busoms C; Martorell Sampol L; García Romero R; Colomé Rivero G; Martín de Carpi J
    Gastroenterol Hepatol; 2022 Oct; 45(8):585-592. PubMed ID: 34942279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
    Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ
    J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients.
    Kruk B; Milkiewicz M; Raszeja-Wyszomirska J; Milkiewicz P; Krawczyk M
    Orphanet J Rare Dis; 2022 Nov; 17(1):419. PubMed ID: 36397154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
    Degiorgio D; Crosignani A; Colombo C; Bordo D; Zuin M; Vassallo E; Syrén ML; Coviello DA; Battezzati PM
    J Gastroenterol; 2016 Mar; 51(3):271-80. PubMed ID: 26324191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
    Reichert MC; Lammert F
    Semin Liver Dis; 2018 Nov; 38(4):299-307. PubMed ID: 30357767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The wide phenotypic and genetic spectrum of ABCB4 gene deficiency: A case series.
    Falcão D; Pedroto I; Moreira T
    Dig Liver Dis; 2022 Feb; 54(2):221-227. PubMed ID: 34376370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults.
    Ziol M; Barbu V; Rosmorduc O; Frassati-Biaggi A; Barget N; Hermelin B; Scheffer GL; Bennouna S; Trinchet JC; Beaugrand M; Ganne-Carrié N
    Gastroenterology; 2008 Jul; 135(1):131-41. PubMed ID: 18482588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
    Moustafa T; Fickert P; Magnes C; Guelly C; Thueringer A; Frank S; Kratky D; Sattler W; Reicher H; Sinner F; Gumhold J; Silbert D; Fauler G; Höfler G; Lass A; Zechner R; Trauner M
    Gastroenterology; 2012 Jan; 142(1):140-151.e12. PubMed ID: 22001865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
    Davit-Spraul A; Gonzales E; Baussan C; Jacquemin E
    Semin Liver Dis; 2010 May; 30(2):134-46. PubMed ID: 20422496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
    Thoeni C; Waldherr R; Scheuerer J; Schmitteckert S; Roeth R; Niesler B; Cutz E; Flechtenmacher C; Goeppert B; Schirmacher P; Lasitschka F
    Can J Gastroenterol Hepatol; 2019; 2019():1085717. PubMed ID: 31886153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of ABCB4 heterozygosity in infants and children with cholestatic liver disease.
    Hegarty R; Gurra O; Tarawally J; Allouni S; Rahman O; Strautnieks S; Kyrana E; Hadzic N; Thompson RJ; Grammatikopoulos T
    J Pediatr Gastroenterol Nutr; 2024 Feb; 78(2):339-349. PubMed ID: 38374565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.